Response-based molecular subtyping—emergence of the third generation of breast cancer subtypes
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference9 articles.
1. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014
2. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials;Denkert;Lancet Oncol.,2021
3. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up;Elston;Histopathology,1991
4. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary Therapy of early Breast Cancer 2011;Goldhirsch;Ann. Oncol.,2011
5. Assessment of Ki67 in breast cancer: Updated recommendations from the International Ki67 in breast cancer working group;Nielsen;J Natl Cancer Inst,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study;Cancer Letters;2024-01
2. Smart DNA sensors‐based molecular identification for cancer subtyping;Smart Molecules;2023-12
3. RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer;Scientific Reports;2023-09-14
4. CYB561 is a potential therapeutic target for BC and is associated with immune cell infiltration;2023-09-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3